BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22085167)

  • 1. Rotarix®: vaccine performance 6 years postlicensure.
    O'Ryan M; Lucero Y; Linhares AC
    Expert Rev Vaccines; 2011 Dec; 10(12):1645-59. PubMed ID: 22085167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
    Kirkwood CD; Boniface K; Barnes GL; Bishop RF
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccines: safety, efficacy and public health impact.
    Gray J
    J Intern Med; 2011 Sep; 270(3):206-14. PubMed ID: 21668823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccination within the South African Expanded Programme on Immunisation.
    Seheri LM; Page NA; Mawela MP; Mphahlele MJ; Steele AD
    Vaccine; 2012 Sep; 30 Suppl 3():C14-20. PubMed ID: 22939015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
    Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
    J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global impact of rotavirus vaccines.
    Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
    Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of rotavirus: Implications for child health.
    Bishop R
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S81-5. PubMed ID: 19799704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccination: a concise review.
    Vesikari T
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus: Genetics, pathogenesis and vaccine advances.
    Sadiq A; Bostan N; Yinda KC; Naseem S; Sattar S
    Rev Med Virol; 2018 Nov; 28(6):e2003. PubMed ID: 30156344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus surveillance--worldwide, 2001-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1255-7. PubMed ID: 19023263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rotavirus vaccines on rotavirus disease.
    Lepage P; Vergison A
    Expert Rev Anti Infect Ther; 2012 May; 10(5):547-61. PubMed ID: 22702319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.